📰 Self Test News
Page 24 - Self Test News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Self Test. Real-time updates on events, politics, business and more.
April 19, 2021
Several different over-the-counter COVID tests will be available to purchase this week at select Massachusetts CVS pharmacies Updated 11:26 AM; CVS Pharmacy on Monday announced that three over-the-counter COVID test kits will be available for purchase this week. The COVID tests include the Ellume COVID-19 Home Test, the Abbott BinaxNOW COVID-19 Antigen Self Test and the Pixel by Labcorp PCR Test Home Collection Kit. All three tests were given emergency use authorization, do not require a presc...
April 19, 2021
(Photo courtesy of CVS Health) For much of the COVID-19 pandemic, Americans have had to go to established testing sites to be tested for the coronavirus, a process that can be time-consuming in driving and wait times for both test and results. CVS Pharmacy, the retail arm of CVS Health, is looking to change that by making three over-the-counter testing options available in its physical and virtual stores. Two deliver test results in 15 minutes. The tests include the Ellume COVID-19 Home Test, t...
April 19, 2021
Multiple over-the-counter COVID-19 tests now available at stores nationwide By Kelly Hayes FDA approves four at-home COVID-19 tests The FDA gave approval for the QuickVue At-Home COVID-19 Test, allowing certain consumers to rapidly test themselves for the coronavirus. Multiple over-the-counter COVID-19 tests will be available at stores nationwide beginning this week, part of the ongoing effort to defeat the pandemic by making testing more widely available in tandem with vaccination. Abbott anno...
April 19, 2021
UpdatedMon, Apr 19, 2021 at 3:20 pm CT Replies(12) BinaxNOW is the cheapest and most accurate COVID-19 at-home test on the market right now, according to the Illinois-based company. The CDC confirmed the accuracy is the highest. (Courtesy Abbott Labs) NORTH CHICAGO, IL — North Chicago-based company Abbott announced on Monday they would begin shipping a new at-home COVID-19 test to three of the largest retailers before the product becomes available nationwide. The BinaxNOW COVID-19 Ag Self Te...
April 7, 2021
Abbott’s stent receives CE mark in Europe for one-month DAPT 7 April 2021 (Last Updated April 7th, 2021 16:28) Abbott’s XIENCE stent has received CE Mark in Europe for shorter, 28-day duration of dual anti-platelet therapy (DAPT) for high bleeding risk (HBR) patients. Abbott’s XIENCE stent has received CE Mark in Europe. Credit: DennisM2 on Flickr. Share Article Abbott’s XIENCE stent has received CE Mark in Europe for a shorter, 28-day du...
April 2, 2021
In-Depth: The simple change that made rapid COVID tests reliable Over-the-counter rapid tests get FDA go-ahead The authorization from the FDA represents a significant endorsement that rapid diagnostics are accurate and effective in even the most challenging testing scenario: evaluating people who are not showing symptoms. and last updated 2021-04-01 21:26:05-04 SAN DIEGO (KGTV) -- COVID-19 self-tests that offer on-the-spot results in minutes will start hitting pharmacy shelves this month, with ...
April 1, 2021
Share this article Share this article SILVER SPRING, Md., March 31, 2021 /PRNewswire/ -- Following recent U.S. Food and Drug Administration actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening. In addition to the tests authorized for OTC use, one serial screening test was author...
April 1, 2021
Abbott announced today it has received U.S. Food and Drug Administration Emergency Use Authorization for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW™ COVID-19 Ag Self Test for detection of COVID-19 infection. This new indication allows individuals with or without symptoms to have access to this test without a prescription. Abbott will begin shipping to major food, drug and mass ...
April 1, 2021
Share this article Share this article ABBOTT PARK, Ill., March 31, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW™ COVID-19 Ag Self Test for detection of COVID-19 infection. This new indication allows individuals with or without symptoms to have access to this test without a prescription. Abbott will begin shipping to ma...
April 1, 2021
Following recent U.S. Food and Drug Administration actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening.